Professor Serhan to guide advancement of resolvin-based therapies into clinical investigation for treatment of inflammatory diseases BRANFORD, CT – (February 19, 2019) – Thetis Pharmaceuticals LLC (“Thetis”), a biopharmaceutical company developing Resolvin-based therapies to treat inflammatory diseases, announced today that Professor Charles N. Serhan has joined its Scientific Advisory Board.